Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 7/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.56 |
| ▸ | RAB9A | P51151 | 4/20 | 0.56 |
| ▸ | MAPT | P10636 | 3/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.56 |
| ▸ | POLB | P06746 | 1/20 | 0.56 |
| ▸ | PKM | P14618 | 1/20 | 0.56 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.47 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.44 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.44 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.44 |
| ▸ | SQOR | Q9Y6N5 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.42 |
| ▸ | HPGD | P15428 | 2/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13776839 | 0.91 | MEN1 (0.54) | MEN1KMT2AALDH1A1RAB9AMAPT | |
| SCHEMBL13203344 | 0.91 | MEN1 (0.54) | MEN1KMT2AALDH1A1RAB9AMAPT | |
| SCHEMBL13776841 | 0.89 | MEN1 (0.59) | MEN1KMT2AALDH1A1RAB9AMAPT | |
| SCHEMBL13776830 | 0.88 | MEN1 (0.51) | MEN1KMT2AALDH1A1RAB9AMAPT | |
| SCHEMBL13776872 | 0.87 | MEN1 (0.50) | MEN1KMT2AALDH1A1RAB9AMAPT | |
| SCHEMBL13776852 | 0.86 | MEN1 (0.56) | MEN1KMT2AALDH1A1RAB9AMAPT | |
| SCHEMBL13776845 | 0.81 | MEN1 (0.59) | MEN1KMT2AALDH1A1RAB9AMAPT | |
| SCHEMBL960513 | 0.80 | CYP19A1 (0.65) | MEN1KMT2AALDH1A1RAB9AMAPT | |
| SCHEMBL13776832 | 0.80 | MEN1 (0.53) | MEN1KMT2AALDH1A1RAB9AMAPT | |
| SCHEMBL13203158 | 0.79 | MEN1 (0.54) | MEN1KMT2AALDH1A1RAB9AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8324403-B2 | Carbazole derivatives; excellent hole transporting property and satisfactory electron transporting, excellent durability against electric oxidation/reduction and a high triplet excitation level; high luminous efficiency and a long lifetime | PIONEER CORPORATION (JP) | 2012-12-04 | — | — | US | disclosed |
| US-20090191426-A2 | ORGANIC COMPOUND, CHARGE-TRANSPORTING MATERIAL, AND ORGANIC ELECTROLUMINESCENT ELEMENT | PIONEER CORPORATION (JP) | 2009-07-30 | — | — | US | disclosed |
| US-20080145699-A1 | Organic Compound, Charge-Transporting Material, and Organic Electroluminescent Element | PIONEER CORPORATION (JP) | 2008-06-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090191426-A2 | ORGANIC COMPOUND, CHARGE-TRANSPORTING MATERIAL, AND ORGANIC ELECTROLUMINESCENT ELEMENT | SLC39A3, SLCO2A1, SLC39A11 | MEN1 2193/4885KMT2A 1792/4885ALDH1A1 2304/4885 |
| US-20080145699-A1 | Organic Compound, Charge-Transporting Material, and Organic Electroluminescent Element | SLC39A3, SLCO2A1, SLC39A11 | MEN1 2193/4885KMT2A 1792/4885ALDH1A1 2304/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.